Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT00591760
Eligibility Criteria:
Inclusion Criteria:
* Heart Failure in ew York Heart Association functional class II to IV
* Left ventricular end diastolic diameter \> 60 mm
* Left ventricular ejection fraction \< 40%
* Growth Hormone Deficiency (defined as a peak GH response to intravenous stimulation with GHRH + Arginine \< 9 ng/dl)
* Age 18-80 years
* Clinical stability, guideline-oriented maximal pharmacological therapy
* Informed consent
Exclusion Criteria:
* Active Myocarditis
* Hypertrophic Cardiomyopathy
* Active endocarditis
* Active malignancy
* End stage renal disease
* Severe liver disease (Child B-C)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00591760
Study Brief:
Protocol Section:
NCT00591760